Here we describe a protocol to generate expandable and multipotent induced cardiac progenitor cells (icpcs) from mouse adult fibroblasts using forced expression of Mesp1, tbx5, Gata4, nkx2.5 and Baf60c (MtGnB) along with activation of Wnt and JaK/stat signaling. this method does not use ips cell factors and thus differs from cell activation and signaling-directed (casD) reprogramming to cardiac progenitors. our method is specific to direct cpc reprogramming, whereas casD reprogramming can generate various cell types depending on culture conditions and raises the possibility of transitioning through a pluripotent cell state. the protocol describes how to isolate and infect primary fibroblasts; induce reprogramming and observe icpc colonies; expand and characterize reprogrammed icpcs by immunostaining, flow cytometry and gene expression; differentiate icpcs in vitro into cardiac-lineage cells; and test the embryonic potency of icpcs via injection into the cardiac crescent of mouse embryos. a scientist experienced in molecular cell biology and embryology can reproduce this protocol in 12-16 weeks. icpcs can be used for studying cardiac biology, drug discovery and regenerative medicine.
IntroDuctIon
Transdifferentiation technology using lineage-specific defined factors has generated a variety of terminally differentiated cell types, including neurons 1 and hepatocytes 2 , without the necessity of going through an intermediate pluripotent cell state. More recently, master regulators of cell fate, as well as culture conditions adapted for expansion in vitro of native tissuespecific stem cells, have been exploited to reprogram fibroblasts into proliferative progenitor cells of neural 3 , hepatic 4 , oligodendrocyte 5 and hematopoietic lineages 6 . Direct reprogramming into cardiomyocytes (CMs) has also been accomplished [7] [8] [9] [10] [11] [12] . However, owing to the lack of consensus on master regulators of the cardiac progenitor cell state and culture conditions required to stabilize cardiac progenitor cells (CPCs) in vitro, reprogramming into expandable CPCs has proven challenging.
Development of the protocol
We recently reported that adult mouse fibroblasts can be directly reprogrammed into expandable iCPCs 13 . iCPCs are cardiacmesoderm-restricted progenitors that can be extensively passaged, and they show multipotency toward cardiovascular lineages (e.g., CMs, smooth muscle cells and endothelium) in vitro, as well as after transplantation into the embryonic cardiac crescent or into the adult postmyocardial infarction heart. iCPCs hold potential advantages over pluripotent stem cell (PSC)-derived cells, as they do not require pluripotent precursor cells. This may be beneficial if iCPCs are used for cell therapy because of a reduced tumorigenic risk. In addition, iCPC reprogramming is more efficient as compared with reprogramming to the induced pluripotent stem cell (iPSC) state followed by differentiation to CPCs 14 . iCPCs hold promise, as they are expandable and have a greater potency for differentiation and repair as compared with directly reprogrammed induced cardiomyocytes (iCMs), which are not expandable, or as compared with adult-heart-derived CPCs that undergo age-related senescence. iCPCs can generate large quantities of desired cardiovascular cell lineages required for drug discovery, and they may serve as a model system for unraveling cardiovascular disease. Overall, iCPC reprogramming technology has potentially broad applications for understanding the molecular mechanism(s) involved in reprogramming, for studying cardiac development and physiology, for modeling cardiovascular diseases and for advancing drug discovery and cardiac regenerative medicine.
We hypothesized that fibroblasts could be reprogrammed into proliferative and multipotent iCPCs using knowledge of embryonic cardiovascular development and defined-factor-mediated reprogramming. Toward this end, we generated a doxycycline-inducible lentivirus library of 22 factors to screen for factors that could reprogram fibroblasts into iCPCs 13 . We used a unique Nkx2.5-EYFP reporter system in which EYFP is specifically expressed at the cardiac progenitor cell stage (E7.5-E9.5) and is turned off during later stages of cardiac development, including the adult heart 15 . The protocol describes a two-stage screening strategy. In Stage 1, we isolated adult fibroblasts from Nkx2.5-EYFP/rtTA double transgenic mice (which do not express Nkx2.5-EYFP) and screened for defined factors and signaling molecules that activated the Nkxreporter and produced proliferative EYFP + colonies. In Stage 2, we assessed whether the resulting EYFP + colonies could be stably expanded without forced expression of cardiac factors. Using this rigorous screening approach, we discovered that five cardiac factors (MTGNB), along with activation of Wnt and JAK-STAT signaling, resulted in complete reprogramming of adult mouse fibroblasts into iCPCs. Figure 1 details the stages involved in reprogramming mouse fibroblasts into iCPCs, and their characterization.
iCPCs are cardiac-mesoderm-restricted progenitors that express CPC transcription factors (TFs), including Nkx2.5, Gata4 and Irx4 (Fig. 2) , and cell surface markers, including Cxcr4, Flk1 and cKit. iCPCs can differentiate in vitro into α-actinin-, α-MHC-, cardiac actin-, MLC-2a-and MLC-2v-expressing CMs, as well as SM-MHC-positive smooth muscle cells and CD31-expressing endothelial cells (Fig. 3) .
Embryonic potency test
CPCs have been identified through the expression of various biomarkers in the developing embryo, in differentiating pluripotent stem cell cultures and in adult heart. They have been characterized extensively in vitro with respect to their gene and protein expression [16] [17] [18] . CPCs can be differentiated in vitro to yield CMs, smooth muscle cells and endothelium, indicating that they are multipotent. However, differentiation is operationally defined 19 , and stem cell potency can be fully evaluated only in the native microenvironment of the organism. Unfortunately, the embryonic potency of most described CPC populations has not undergone such rigorous scrutiny. If iCPCs are bona fide progenitor cells of the cardiac lineage, we reasoned that they should respond to cardiomorphogenic signals present in the embryonic cardiac crescent and differentiate into CMs, especially as our Nkx2.5-EYFP reporter identifies embryonic CPCs. Hence, we injected iCPCs into the cardiac crescent of mouse embryos, where native CPCs are present, and assessed their differentiation potential. iCPCs indeed integrated into the developing heart tube and differentiated into CMs 13 .
Comparison with other methods
Direct reprogramming of fibroblasts to iCMs was accomplished in 2010 by Ieda et al. 8 . They reported in vitro transdifferentiation of mouse neonatal cardiac fibroblasts into iCMs using three TFs: Gata4, Tbx5 and Mef2c (GMT) 8 . Subsequently, a number of groups reported iCM reprogramming in both mouse and human cells using various combinations of TFs, as well as microRNAs 7, [9] [10] [11] [12] . A detailed protocol to reprogram mouse cardiac neonatal fibroblasts into iCMs using GMT has previously been published 20 . Recently, direct reprogramming of human fibroblasts into iCMs has been achieved using small molecules only 21 . iCM reprogramming in vivo has also been demonstrated in the mouse heart via viral delivery of cardiac factors following myocardial infarction 22, 23 . However, the above reports also provided evidence that iCM reprogramming does not pass through a cardiac progenitor intermediate. iCMs such as CMs are terminally differentiated nonproliferative cells. Combined with low in vitro reprogramming efficiency, this may not yield the required quantity of cells for regenerative medicine applications or drug discovery. By contrast, reprogramming to a cardiac progenitor cell state has several advantages. Cardiac progenitors are multipotent and can differentiate into not only CMs but also into smooth muscle and endothelial cells, which are the necessary complement of cells required to fully reconstitute the damaged heart. Moreover, cardiac progenitors are proliferative and hence scalable to yield large quantities of desired cells (progenitors or differentiated progeny). An initial study aiming to reprogram human fibroblasts to cardiac progenitors was unable to isolate and stabilize a proliferative, multipotent progenitor cell 24 .
We first reported lineage reprogramming of fibroblasts into expandable and multipotent cardiac progenitor cells 13 . Independently, Zhang et al. confirmed this finding using an alternative method 25 . Although both reprogramming methods generate cardiac progenitors, the approaches are fundamentally different. Specifically, Zhang et al. used mouse embryonic fibroblasts (MEFs) derived from a transgenic mouse line that was engineered to express Yamanaka-iPSC factors upon addition of doxycycline, called 'secondary MEFs'. Further, they used transient expression of iPSC factors in secondary MEFs to induce a partially reprogrammed epigenetically unstable cell state, which could be directed toward a CPC state using signaling molecules that included Bmp4, Activin A and Wnt activation (CHIR99021), while at the same time inhibiting signaling by FGF, VEGF, PDGF, (SU5402) and JAK/STAT (JI1). This approach is referred to as 'CASD reprogramming' and has been used by the same group to reprogram fibroblasts into various cell types, including CMs, hepatocytes and neural stem cells 20, 26 . Thus, the CASD reprogramming system is not specific to the CPC state, but rather it has the potential to generate cell types derived from all three germ layers depending upon the signaling pathways used. Recent reports have suggested that transdifferentiation to both CMs and neural stem cells using CASD reprogramming transitions through an intermediate pluripotent state, which raises tumorigenic 
Applications and limitations of the protocol
The current protocol uses lentiviruses that encode cardiac factors for reprogramming; these integrate into the genome, which can produce undesired integration effects. However, the protocol can be adapted to test integration-free methods such as episomal vectors, Sendai viruses or modified mRNAs. The protocol can also be optimized for screening small molecules that improve reprogramming efficiencies or to replace defined factors. Using the in vitro differentiation protocol described here, the majority of iCPCs differentiate into CMs. However, the differentiation protocol can be adapted to suit differentiation into smooth muscle cells and endothelial cells. This protocol uses adult mouse fibroblasts as the starting source for reprogramming. In our experience, mouse fibroblast cultures can contain karyotypically abnormal cells, which may result in chromosomal abnormalities in resulting iCPCs. Hence, we recommend screening to identify karyotypically normal iCPC lines. Other investigators have reported that lineage reprogramming protocols optimized for mouse cells can require substantial adaptation to enable reprogramming of human cells 11, 12 . The majority of direct reprogramming protocols have been discovered using mouse embryonic or neonatal cells, which, even though they are epigenetically more amenable to reprogramming, are less clinically relevant, as comparable human cells are not available. Our protocol has been developed for reprogramming adult mouse fibroblasts, for which clinically relevant human cells are available. Hence, this protocol could facilitate reprogramming of human fibroblasts into iCPCs, which will be an important step in potentially advancing this technology to human cardiac regenerative medicine. The screening strategy and characterization criteria described in this protocol can be used to derive and benchmark novel CPC populations from embryos and pluripotent stem cells, as well as from the adult heart. The unique embryo injection model described here can be used to test the embryonic potency of other identified CPC populations, including CPCs derived from pluripotent stem cells 29 and adult-heart-derived CPCs. In addition to testing potency of cardiac cells, this protocol can be used to test the potency of cells for other mesodermal cell types, as well as for definitive ectoderm, definitive endoderm and extra-embryonic cell types, by injecting them into respective test sites. A limitation of the whole-embryo culture technique presented here is that it has been designed to culture embryos ex vivo for 24-48 h until they reach E9.5. We have not tested culturing embryos beyond E9.5 using this setup.
Experimental design
Starting cell source. This protocol was developed using adult mouse fibroblasts as a starting cell source for reprogramming. It is critical to have healthy and proliferative fibroblast cultures for reprogramming. Hence, we recommend using fibroblasts that are between 0 and 3 passages. In addition, the cardiac factor viruses used in this protocol are doxycycline-inducible, and they require coexpression of the reverse tetracycline trans-activator (rtTA) protein in order to be functional. It is important to confirm α-Actinin 
Forceps, two pairs, fine, straight, no. Polybrene solution (10 mg/ml stock solution) Add 100 mg of polybrene powder to 10 ml of PBS and filter-sterilize the solution using a 0.45-µm syringe filter. Dispense the stock as 1-ml aliquots in sterile tubes and store them at −20 °C indefinitely. Add 0.8 µl/ml for a final concentration of 8 µg/ml. Thaw just before use and discard any unused stock-do not refreeze. HEK culture medium This medium contains 10% (vol/vol) heat-inactivated FBS, 1% (vol/vol) penicillin-streptomycin, 1% (vol/vol) nonessential amino acids and 1% (vol/vol) l-glutamine in DMEM.
To make 500 ml of HEK medium, add 50 ml of heat-inactivated FBS, 5 ml of 1% (vol/vol) penicillin/streptomycin, 5 ml of 100× nonessential amino acids and 5 ml of 1% (vol/vol) l-glutamine to 435 ml of DMEM and filter-sterilize the medium through a 0.2-µm filter. Store HEK culture medium at 4 °C for up to 2 months.  crItIcal Optimal HEK growth must be confirmed for each new FBS lot before use.
•
Fibroblast medium This medium contains 10% (vol/vol) heat-inactivated FBS, 1% (vol/vol) penicillin-streptomycin, 1% (vol/vol) nonessential amino acids and 1% l-glutamine (vol/vol) in DMEM. To make 500 ml of fibroblast medium, add 50 ml of FBS, 5 ml of 1% (vol/vol) penicillin-streptomycin, 5 ml of 100× nonessential amino acids and 5 ml of 1% (vol/vol) l-glutamine to 435 ml of DMEM and filter-sterilize the medium through a 0.2-µm filter. Store the fibroblast medium at 4 °C for up to 2 months. FBS lots must be tested for efficient cardiac differentiation using mESCs before use. iCPC induction medium This medium contains a final concentration of 8 µg/ml doxycycline, 2.5 µM BIO and 10 3 units of LIF per ml, all in fibroblast medium. To make 1 ml of iCPC induction medium, add 4 µl of doxycycline, 1 µl of LIF (10 3 units, add directly from vial) and 0.25 µl of BIO solution to 1 ml of fibroblast medium. Freshly prepare the medium before use. iCPC maintenance medium This medium contains 2.5 µM BIO and 10 3 units of LIF per ml in fibroblast medium. To make 1 ml of iCPC maintenance medium, add 1 µl of LIF (10 3 units, add directly from vial) and 0.25 µl of BIO solution to 1 ml of fibroblast medium. Freshly prepare the medium before use. iCPC differentiation medium This medium contains 50 ng/ml BMP4, 30 ng/ml FGF2, 10 ng/ml VEGF and 5 µM IWP4, all in fibroblast medium.
To make 1 ml of iCPC differentiation medium, add 0. To make 500 ml of iCPC differentiation maintenance medium, add 5 ml of heat-inactivated FBS, 5 ml of 1% (vol/vol) penicillin-streptomycin, 5 ml of 100× nonessential amino acids and 5 ml of 1% (vol/vol) l-glutamine to 435 ml of DMEM; filter-sterilize the medium through a 0.2-µm filter. Store the medium at 4 °C for up to 2 months.
2× Freezing medium and cryopreservation of mouse fibroblasts
This medium contains fibroblast medium, DMSO and heat-inactivated FBS in a 3:1:1 ratio (vol/vol/vol). To make 10 ml of 2× freezing medium, mix 6 ml of fibroblast medium, 2 ml of DMSO and 2 ml of heat-inactivated FBS in a 50-ml conical tube and filter-sterilize the medium through a 0.2-µm filter. Store the medium at 4 °C for up to 1 month. Add 0.5 ml of 2× freezing medium to 0. Blocking solution Blocking solution contains 5% (wt/vol) BSA, 2% (vol/vol) serum and 0.1% (vol/vol) Triton X-100 (optional). To make blocking solution, add 2.5 g of BSA, 1 ml of goat or donkey serum and 50 µl of Triton X-100 to a 50-ml conical tube and add PBS (nonsterile) to the 50-ml mark. Gently mix and store the solution at 4 °C for up to 6 months. Do not add Triton X-100 when immunostaining for cell surface markers. Flow cytometry blocking solution This solution contains 5% (wt/vol) BSA and 2% (vol/vol) goat serum. To make flow cytometry blocking solution, add 2.5 g of BSA and 1 ml of goat serum to a 50-ml conical tube, and add PBS (nonsterile) to the 50-ml mark. Mix by hand and store the solution at 4 °C for up to 6 months. Tissue culture incubator conditions Set the incubator to 37 °C, 5% CO 2 and high humidity. Make sure that the tray in the incubator is always filled with deionized water.
Timed matings of mice for embryo isolation
We use a 12-h light/dark cycle and a 'reversed lighting' scheme (lights off/on at 1 pm/1 am) to obtain crescent-stage embryos mid-afternoon. Just before the lights go off (1 pm), proestrus and estrus females of breeding age are selected by examining the external genitalia for four signs: pink (proestrus) to white (estrus), swollen, gaping and crinkled 31, 32 . An individual proestrus or estrus female is then placed with a male stud of breeding age. Several hours later (~4:30 pm), copulation plugs are checked during the dark cycle with the aid of a red light. Although the copulation plug is generally obvious upon visual inspection with the F1 inbred hybrid strain (B6CBA/J), nevertheless, rounded forceps are always used to probe the vaginal opening for evidence of a hard 'plug' . Once copulation has taken place, the plug of semen persists for up to 14-16 h. Metestrus, when vaginal discharge is present 32 , may be mistaken for a copulation plug. However, although this discharge appears coagulated, it is not solid, as determined by the forceps. If a plug is detected at 4:30 pm, the plugged female remains with the stud male overnight. Check for plugs no later than 14-16 h after beginning of the dark cycle, or you risk missing a plug because of dissolution. The next morning when the lights are on, check for more plugs; the early-plugged females are housed separately from the later-plugged ones, and they are dissected several hours in advance of the later-plugged ones. Alternatively, if the males are not needed for mating over the next week, you may leave the plugged females with the males until the day of the experiment. If your female did not hold her litter and you are sure that you detected a plug, investigate lighting, movement in and out of the rooms when the lights are off and noise/construction-eliminate all these factors. Set up timed matings on two successive nights 8 d in advance of your injection (for several reasons, including loss of pregnancy, too many resorptions per litter or incorrect stages). This way, you will be able to use the precious whole-embryo culture medium on the second day. Forceps for embryo dissection Purchased forceps must be crafted after purchase 30 using an Arkansas sharpening stone (e.g., VWR International, cat. no. 100502-466). Briefly, the tines should be of equal length and thickness in frontal and sagittal profiles. Tines should come to a tapered point when viewed in frontal profile and should meet at their tips when gently squeezed together and viewed in sagittal profile. Before dissecting conceptuses, clean your forceps with soap and water, followed by rinsing in tap and dH 2 O, and absolute alcohol. Do not flame the forceps. 100× amino acid solution This solution is used in embryo dissection medium and whole-embryo culture medium. The following amounts are for 1,000 ml. To a sterile 1,000-ml graduated cylinder, add a stir flea, and ~900 ml of tissueculture-grade sterile double-distilled water. While stirring on a mixing plate, add 4.80 g of cysteine-HCl, 3.60 g of l-alanine, 6.00 mg of l-asparagine, 5.30 g of l-aspartic acid, 4.60 g of l-proline and 5.90 g of l-glutamic acid, and stir. The powders will not go into solution until pH 9.0 is achieved . Adjust the pH to 9.0 by dispensing ≈550 drops (100 drops = 2.25 ml) of 5N NaOH administered from a 9-inch sterile Pasteur pipette. Do not filter-sterilize at this point; dispense the solution in 10-ml aliquots and store them indefinitely at −80 °C. A piece of wider-gauge latex tubing is then secured over the adaptor and connected to the gas outlet. The round mouthpiece (2) is replaced by a flat mouthpiece that is inserted into a disposable filter (0.22 or 0.45 µm) using Parafilm to create a tight seal (not shown). The filter is then secured to a longer piece of latex tubing, followed by the microcapillary and its gasket, which securely holds an injection pipette. (d) The microflame (left) will be secured to a clamp (right) and connected to the gas outlet (not shown). (e) The microflame is ignited. (f,g) A piece of glass microtubing is briefly softened at its center (f) and, when red hot, is removed from the flame and pulled horizontally (g). (h,i) The pulled microcapillary is loaded onto an electrode puller, the trough filament of which is heated (h), and the glass is then pulled, creating two tapered glass capillaries (i, only one is shown). Embryo dissection medium This medium is buffered for use in atmospheric oxygen. To make 1,000 ml of embryo dissection medium, add the ingredients in the following order to ~800 ml of tissue-culture-grade double-distilled water in a 1,000-ml graduated cylinder with a stir flea on a mixing plate: 13.5 g of DMEM, 2.4 g of HEPES, 0.8 g of NaCl, 10 ml of 100× amino acid solution, 2 ml of 5,000 U/ml penicillin-streptomycin and 75 ml with tissueculture-grade ddH 2 O. of heat-inactivated FCS. Adjust the pH to 7.4 with ≈25 drops of 5 N NaOH delivered with a 9-inch Pasteur pipette and monitor with either a pH meter or color pHast indicator strips. Adjust the final volume to 1,000 ml with tissue-culture-grade ddH 2 O. Filter-sterilize through a 0.22-µm cellulose acetate filter. Prepare aliquots of dissection medium in sterile 50-ml polypropylene tubes (do not overfill, as the medium will expand upon freezing) and store the tubes indefinitely at −80 °C. Warm the medium to RT before use. Store unused thawed medium at 4 °C for up to 1 month. Incomplete whole-embryo culture medium (without serum) This medium is buffered for use in a tissue culture incubator. To make 1,000 ml of whole-embryo culture medium (without serum), add the ingredients in the following order to ~800 ml of tissue-culture-grade double-distilled water in a 1,000-ml graduated cylinder with a stir flea on a mixing plate: 13.5 g of DMEM, 3.7g of NaHCO 3 , 10 ml of 100× amino acid solution and 2 ml of 5,000 U/ml penicillin-streptomycin. Bring the volume to 1,000 ml with tissueculture-grade ddH 2 0. Divide in half and transfer 2 × 500 ml to two sterile 1,000-ml Erlenmeyer flasks. Adjust the pH in each 500-ml aliquot to 6.5-7.3 by bubbling CO 2 directly into the flasks with the aid of tubing attached at one end to the gas cylinder and the other to a cotton-plugged 9-inch Pasteur pipette. Filter-sterilize through a 0.22-µm cellulose acetate filter. Prepare aliquots of whole-embryo culture medium in sterile 50-ml polypropylene tubes (do not overfill, as the medium will expand upon freezing) and store them indefinitely at −80 °C; when frozen, the color of the medium will be yellow (Fig. 4a) , and when thawed the color will turn red; mix well by gentle inversion. Unused thawed medium can be stored at 4 °C for up to 1 month. Complete whole-embryo culture medium (with rat serum and heat-and gas-equilibration) On the day of the cell injection, calculate the number of conceptuses that you expect to inject and culture. In your media calculations, include an extra 1 ml of medium to be distributed to two 'holding' organ culture dishes to maintain the embryos during the injection procedure. For the first 24 h, individual or pairs of embryos will be cultured in 1 ml of culture medium. For the second 24 h, individual embryos will be cultured in 1 ml of culture medium. Label an appropriate number of whole-embryo culture tubes for the first day and loosen the caps. Prepare rat serum as described 33 to avoid hemolysis. Commercially available rat serum may be used, provided that it is not hemolyzed (Fig. 4b) . Store rat serum in 1-, 2-or 3-ml aliquots indefinitely at −80 °C. Once thawed, rat serum cannot be refrozen. Thaw rat serum in a small beaker of water (~10 min). Heat-inactivate thawed rat serum at 56 °C for 30 min (exactly) to inactivate complement. Be sure that the water entirely covers the serum. Spin heat-inactivated rat serum for 5 min, at 1,625g at RT, to bring unwanted solids to the bottom of the conical cryotube. With a sterile 9-inch Pasteur pipette, transfer all but the bottom-most serum to a sterile 50-ml polypropylene tube. It is important that you add the serum to the test tube before adding the incomplete culture medium, in case you spill some.
Add an equal volume of incomplete whole-embryo culture medium (without rat serum) via a sterile 5-ml disposable volumetric pipette attached to a dedicated automated pipettor. Distribute 1 ml of complete culture medium to each embryo culture tube, and 500 µl of extra culture medium to each of two organ culture dishes. With the caps in the loose position, balance the culture tubes against each other in the incubator's roller apparatus, placed at 8° off the horizontal, and roll at 0.5 r.p.m.; the organ culture dishes remain stationary. Gas-and temperature-equilibrate the complete whole-embryo culture medium for at least 1 h before placing embryos into the tubes. When equilibrated, the color of the medium will be fleshy pink. Any unused medium can be stored for up to 24 h at 4 °C and used the next day only. Medium can be stored in either the embryo culture tubes with the caps closed securely (gas-and heat-equilibrate it the next day after loosening the caps) or a large 50-ml sterile polypropylene tube.
Mouth aspirator This is used to inject cells into the cardiac crescent.
The mouth aspirator is fixed to an injection pipette, which is used to inject cells of interest into the cardiac crescent. Sigma-Aldrich supplies mouth aspirator tube assemblies that come with a round mouth aspirator, about a foot of latex tubing and a microcapillary holder. However, the only piece of this assembly we use is the capillary holder, which is used both to make the mouth aspirator and serve as an adaptor for the microflame. The rest of the aspirator assembly is not ideal, as the round mouthpieces are inferior to the flat ones in terms of suction control, and the latex tubing supplied with the mouth aspirator assemblies is too short for comfortable work. Microflame. Gently prestretch the thin-walled microcapillary tubing by placing the central portion over the microflame until it is red hot. Remove the capillary from the flame and gently pull, but do not break it into two pieces (Fig. 4f,g ).  crItIcal step Do not fuse the glass, or you will not be able to inject cells. 2. Electrode puller. Place the central pulled portion of the stretched microcapillary over the platinum trough filament of an electrode puller. Pull to produce a tapered pipette of varying diameter (~1-80 µm) (Fig. 4h,i) . The amount of pull, and time and speed of pulling should be empirically determined with the aid of the instruction manual for your equipment. 3. Microforge. You can either insert the pulled pipette into a Leitz instrument holder and insert into the microforge or you can insert the pipette directly into the microforge, if it will accommodate a 'naked' pipette. Align the glass platinum filament's bead to just beneath the point where the capillary's internal diameter is 20 µm, and make sure that both the bead and capillary are in the same focal plane. Place the bead onto the underside of the capillary, and heat the filament so that the glass bead is slightly red hot, thereby fusing the bead to the filament. Turn off the heating element of the microforge. The cooled glass bead will contract, resulting in a clean break of the microcapillary at 20 µm. To remove the excess glass from the bead, strike it off with a glass pipette and turn on the heat to melt the remainder into the glass bead. Then, if desired, flame-polish the end of the pipette by placing the capillary at an appropriate distance from the glass bead, without any chance of fusing them (Fig. 4j) . Reheat the glass bead until the end of the microcapillary softens. Turn off the filament. The injection tips should be smooth, never jagged. Microcapillaries can be stored in a purpose-built box containing an insert of flexible foam that has been glued to the bottom of the box and scored with a razor blade (Fig. 4k) . width, 1/32 inch). Remove the rubber gasket that holds a glass capillary, and place the funnel portion of the assembly capillary holder into the latex tubing. Connect the wide end of the capillary holder to a piece of rubber tubing and connect the latter to the gas outlet. The needle is vertically supported in a clamp secured onto a ring stand. Place the hosecock clamp (optional) near the middle of the tubing, and tighten slightly to regulate the gas flow (Fig. 4d,e) . Wide-bore Pasteur pipettes Sterile 9-inch-long Pasteur pipettes are useful for the transfer of early gastrulating embryos, but postculture embryos are best transferred with wider-bore pipettes. Score the wide part of a Pasteur pipette with a diamond tip glass scorer and break it off with your fingers. The cut end of the wide-bore pipettes should be flush, never jagged. Wide-bore pipettes can be placed into a small metal canister and sterilized; however, because embryo culture is short-term and the dissection and culture media contain antibiotics, autoclaving is not necessary.
! cautIon Be sure to wear safety goggles during this procedure. Injection pipettes Injection pipettes are used to inject cells into the cardiac region. They are made as described in Box 2. See also Figure 4f -k. Whole-embryo culture incubator conditions Embryos should be kept in a humidified water-jacketed incubator set to 6.2% CO 2 and 37 °C. Alternatively, 5% CO 2 may be used. Embryo blocking solution Embryo blocking solution is used for whole-mount immunostaining of embryos. This solution contains 5% (vol/vol) serum and 0.1% (vol/vol) Triton X-100. To make embryo blocking solution, add 2.5 ml of goat or donkey serum (or another animal serum, depending upon the species in which the antibodies were raised) and 50 µl of Triton X-100 to a 50-ml polypropylene conical tube containing 47 ml of PBS. Mix gently by inversion. Freshly prepare the solution and use it for 2-3 d with storage at 4 °C.
proceDure Isolation of adult cardiac, lung and tail-tip fibroblasts from nkx2.5-eYFp/rtta transgenic mice • tIMInG 12-14 d  crItIcal Confirm the genotype of the mice by performing RT-PCR on genomic DNA to verify the presence of rtTA and Nkx-EYFP transgenes before tissue isolation. The following procedure can be used for male and female mice ranging from 1 to 3 months in age. 1| Tissue isolation. Anesthetize the mice using isoflurane and place them in a tissue culture hood designated for primary tissue isolation. Disinfect the chest and tail area with 70% (vol/vol) ethanol before proceeding to dissection. ! cautIon Experiments using mice must be performed in accordance with the relevant institutional and governmental regulations.
? trouBlesHootInG 2| Dissect heart, lung and/or tail from mice and place them in cold sterile PBS in a separate 10-cm tissue culture dish for each organ to wash off residual blood. For tail tissue, remove epidermis using scissors and forceps.  crItIcal step Thoroughly wash tissue to remove as much blood as possible. Use sterile equipment and aseptic technique to avoid contaminating fibroblast cultures. All isolation steps must be performed inside a tissue culture hood. ? trouBlesHootInG
3|
Transfer washed tissue to a fresh sterile 10-cm tissue culture dish containing 3-4 ml of cold fibroblast medium. Tilt the dish and mince the tissue using scissors to obtain tissue pieces <1 mm 3 in size. Tissue should be minced immediately after harvest.  crItIcal step Mince quickly to obtain tissue chunks that are as small as possible. Smaller tissue chunks attach faster than large ones, and are optimal for explant culture. If fibroblasts are being derived from multiple sources, make sure to avoid tissue cross-contamination. Do not reuse equipment and reagents for different tissue sources. ? trouBlesHootInG
4|
Cut the end of a 1-ml pipette tip with sterile scissors to allow tissue pieces to be pipetted. Using this tip, transfer the minced tissue pieces to a sterile 15-ml conical tube. Wash the dish used for mincing 1-2 times with cold sterile PBS to collect all tissue pieces.
5|
Centrifuge the tube at RT for 2 min at 200g. Aspirate the supernatant and discard it.
6|
Resuspend the pellet of tissue pieces in 5 ml of cold sterile PBS. Centrifuge at RT for 2 min at 200g, aspirate the supernatant and discard it.
7|
Setup of explant culture. Resuspend heart/lung tissue pieces in 4 ml of warm (37 °C) fibroblast medium and tail tissue pieces in 2-3 ml of warm fibroblast medium. Plate 5 ml of warm fibroblast medium per 10-cm dish (gelatinized) and add 1 ml of medium containing tissue pieces (total 6 ml/dish). Thus, one adult heart/lung should be plated onto four 10-cm dishes, and tail tissue pieces should be plated on two or three 10-cm dishes, depending on the size of the initial tail tissue dissected.  crItIcal step Make sure that the tissue pieces are evenly distributed among the dishes and within individual dishes. Do not use more than 6 ml of fibroblast medium per dish; this is the optimal medium volume for tissue attachment and fibroblast migration.
8|
Place dishes in the incubator and culture them for 7 d.  crItIcal step Do not disturb dishes during this culture period, as frequent movement hampers tissue attachment.
? trouBlesHootInG 9| At the end of 7 d, observe the explant culture plates in a tissue culture microscope. Most viable tissue pieces should be attached and Nkx2.5-EYFP -fibroblasts should have migrated from tissue pieces (Fig. 2a) . Change the medium at this stage and culture for additional 5-7 d depending on the rate of fibroblast migration.
? trouBlesHootInG 10| Passage fibroblasts 1-2 times, proceed immediately to set up reprogramming experiments or freeze them for future use. We have not seen significant differences between freshly isolated, passaged and frozen fibroblasts with respect to reprogramming outcome or efficiency. However, the majority of our experiments were with frozen fibroblasts between passages 1 and 2. Cardiac and lung fibroblasts are more proliferative than tail-tip fibroblasts and show higher reprogramming efficiencies as compared with tail-tip fibroblasts.
? trouBlesHootInG
Day-2-seeding of mouse fibroblasts for lentivirus infection • tIMInG 2 d for fibroblasts in culture, 5-6 d for frozen fibroblasts  crItIcal
The following procedure has been optimized for adult mouse cardiac, lung and tail-tip fibroblasts. However, we recommend starting with cardiac fibroblasts because iCPC reprogramming is most efficient when starting with cardiac fibroblasts. 11| Culture of fibroblasts on gelatinized 10-cm dishes. If you are using previously frozen fibroblasts, culture them for 3-4 d in fibroblast medium before setting up for infection. Fibroblasts should not express Nkx-EYFP (Fig. 2a) .
12| Aspirate the medium from the fibroblast dish and wash with 3-4 ml of sterile PBS.
13|
Warm 0.25% (vol/vol) trypsin-EDTA to 37 °C, aspirate the PBS and add 1.5 ml of warm 0.25% trypsin-EDTA. Tilt the plate from side to side to ensure that the trypsin covers the entire surface area of the plate. Place in a tissue culture incubator for 5-10 min.  crItIcal step Monitor the plate under a microscope every 3-4 min to detect cell detachment. Tap the plates with the palms of your hands to facilitate detachment. Trypsinization should be stopped when >90% of the cells have detached and can be observed floating. Prolonged trypsinization should be avoided, as it reduces cell viability.
14| Add 1.5 ml of fibroblast medium to the plate to quench the trypsin. Mix and thoroughly wash the entire surface of the plate using a 5-ml pipette to remove any undetached cells from the plate.
15|
Place a 40-µm cell strainer on top of a 50-ml sterile polypropylene conical tube and pass the cells through the filter to eliminate tissue pieces.
16| Add 5 ml of sterile PBS to the dish, wash thoroughly and pass again through the same cell strainer to collect the cells in the 50-ml conical tube from Step 5.
17|
Centrifuge the cells at 200g for 5 min at RT. Aspirate the supernatant and resuspend the cell pellet in 2-3 ml of fibroblast medium.
18|
Count the cells using a hemocytometer and seed 50,000 cells per well in a gelatinized 12-well plate.  crItIcal step Reprogramming using this protocol is optimal when starting with 50,000 cells per well (12-well plate).
19|
Place the plate in an incubator and culture it for 2 d.
Day 0-lentiviral infection of mouse fibroblasts • tIMInG 2 d 20| Add 0.8 µl/ml polybrene solution to the lentivirus supernatant in a sterile 15-ml conical tube and mix thoroughly. Use fresh lentivirus supernatant or thaw frozen lentivirus in a 37 °C water bath. Production of lentiviral supernatant is described in Box 1. As an alternative, commercially available lentiviral vector systems and even complete commercial lentiviral particle production are available, but we have not tested these systems. ! cautIon All equipment, including pipettes and dishes, that comes into contact with the lentiviral supernatant should be treated with 10% bleach followed by ultraviolent light for at least 1 h before discarding.  crItIcal step Addition of polybrene enhances lentivirus transduction efficiency. Thawed lentivirus supernatant should be used immediately to infect fibroblasts. 21| Aspirate the medium from the fibroblast wells and add 2.5 ml of lentiviral supernatant per well (supplemented with polybrene) to initiate virus infections.  crItIcal step Fibroblasts should be 90-95% confluent, at which point lentivirus infection is optimal. Infecting less confluent cells may lead to cell death or reduced viability during subsequent reprogramming steps.  crItIcal step For each batch of infection using cardiac factors, one well should be infected with pSAM2 GFP lentivirus that was produced alongside the cardiac factor viruses. This is an important control to account for batch-to-batch variability in lentivirus production.
22|
Return the plates to the incubator for 2 d.
Day 2-induction of reprogramming • tIMInG 2 d 23|
Use a 5-ml pipette to remove the lentivirus supernatant from the cells and discard in 10% bleach solution. Wash the cells with 1 ml of PBS per well using a 5-ml pipette, and discard the PBS in 10% bleach solution.
24| Add 8 µl/ml doxycycline solution to the fibroblast medium and feed the infected cells with 1 ml of medium per well.
25|
Day 4-introduction of cpc culture conditions and splitting • tIMInG 1 h 26|
Remove the plate from the incubator and observe the well infected with control pSAM2 GFP lentivirus under the green channel of an epifluorescence microscope. >>80% of the cells should appear to be GFP + . All pSAM2 vectors have IRES mCherry engineered downstream of GFP/cardiac factors, and hence the majority of GFP + cells should show mCherry expression (Fig. 2b) . mCherry expression should also be detected in wells infected with cardiac factors. For unknown reasons, mCherry expression is brighter in lung and tail-tip fibroblasts relative to cardiac fibroblasts.  crItIcal step For each batch of reprogramming experiments, it is important to confirm GFP expression in >80% of cells in the control well. This ensures that the cells have rtTA expression and that lentivirus production was efficient.
If the infection efficiency is <80%, we recommend starting with fresh cells and a fresh virus batch. ? trouBlesHootInG 27| Aspirate the medium from the wells and wash the cells with PBS.
28|
Aspirate the PBS and add 0.5 ml of warm 0.25% trypsin-EDTA to each well and return the plate to the incubator for 5-10 min.  crItIcal step Monitor the plate under a microscope every 3-4 min to detect cell detachment. Tap the plates with the palms of your hands to facilitate detachment. Trypsinization should be stopped when >90% of cells have detached and can be observed floating. Prolonged trypsinization should be avoided, as it reduces cell viability.
29|
Using a 1-ml pipette, quench the trypsin by adding 0.5 ml of warm fibroblast medium to each well. Using a 1-ml pipette, mix and thoroughly wash the entire surface of the well to remove any undetached cells from the well. Collect the cells in a sterile 15-ml conical tube. Wash each well with 1 ml of sterile PBS and collect in the sterile 15-ml tube.
30| Centrifuge cells at 200g for 4.5 min at RT. While the cells are spinning, prepare iCPC induction medium.
31|
Aspirate the supernatant and resuspend the cells in 3 ml of iCPC induction medium per starting well. Seed the cells onto gelatinized 60-mm dishes and return them to the incubator.  crItIcal step Each infected well (12-well plate) should be transferred to one 60-mm dish (1:5 to 1:6 split). This will result in a starting cell confluency of 30-40% and is the optimal cell density for iCPC reprogramming. Splitting cells sparsely at this stage will severely hamper reprogramming. 34| Assess for the appearance of EYFP + proliferative iCPC colonies 2 weeks after doxycycline induction. Fibroblasts undergoing reprogramming become proliferative, lose parental fibroblast morphology, exhibit a high nuclear-cytoplasmic ratio (iCPC morphology) and express Nkx-EYFP (Fig. 2c) . Cells undergoing iCPC reprogramming can be easily identified based on this marked morphological change. Allow iCPC colonies to expand for an additional 10-16 d.
? trouBlesHootInG 35| After 3-4 weeks of doxycycline induction, the 2D iCPC colonies reach 3-4 mm in size. They should be scored at this stage based on the expression of EYFP and iCPC morphology (Fig. 2d) . iCPC colonies may express mCherry along with EYFP, indicating that cells undergoing reprogramming are overexpressing cardiac factors (Fig. 2e) . Typically, if you started with 50,000 cells, 5-15 iCPC colonies will be detected (0.01-0.03% reprogramming efficiency). The reprogramming efficiency will vary according to fibroblast source. Colonies can be split after scoring. Step 36A(i-iv). Aspirate the supernatant and resuspend the cells in 6 ml of iCPC maintenance medium using a 1:6 split ratio, and plate cells on a gelatinized 100-mm dish. For subsequent passages, iCPCs can be split every 5-6 d using a 1:6 to 1:8 split ratio as desired using iCPC maintenance medium. Cells maintain Nkx-EYFP expression and iCPC morphology for at least 30 passages (Fig. 2f) .
? trouBlesHootInG  pause poInt iCPC lines can be frozen and stored in liquid nitrogen for several years. >95% of iCPCs express Nkx2.5, Gata4 and Irx4 (Fig. 2g) .  pause poInt Coverslips that have been accurately mounted and cured using antifade solution can be stored at 4 °C in the dark for several months without losing signal intensity. Alternatively, RNA can be used to perform genome-wide gene expression assessment via microarray or RNA-seq analysis.  crItIcal step All qPCR experiments, including primer design, should be performed in accordance with the MIQE guidelines 34 .
Differentiation of icpcs into cardiac-lineage cells • tIMInG 4-8 weeks 38|
Dissociate iCPCs into single cells using 0.25% trypsin and seed at a density of 400,000-500,000 cells/ml in iCPC differentiation medium and add 0.5 ml of cell suspension to the desired number of wells of a 24-well low-attachment plate. Place the plate in an incubator and culture it for 4-6 d. iCPCs aggregate into embryoid-body-like spheres during this period.
39|
Transfer the iCPC aggregates to gelatinized regular 24-well plates and culture them for 24 h. Aggregates attach to plates during this culture period.  crItIcal step Transfer the aggregates from one low-attachment well (24-well plate) to one gelatinized regular well (24-well plate).
40|
Carefully aspirate the medium without detaching aggregates, and add 0.5 ml of differentiation maintenance medium to each well. Feed the cells on a weekly basis. iCPC-differentiated cells can be cultured for up to 6 months in differentiation maintenance medium.  crItIcal step Do not split the cells after initiation of differentiation, even if they become confluent.
41|
Immunostain a subset of iCPC-differentiated cells with cardiac-lineage differentiation makers such as cardiac actin, α-MHC, α-actinin, MLC-2v, SM-MHC and CD31, as detailed in Step 37B, to ensure that they are the correct lineage before proceeding with the next step. (Fig. 3a) . (v) Sterilize the abdomen with ethanol, and make an incision orthogonal to the body axis at the level of the upper thigh of the mouse. With your hands, pull the skin on either side of the incision simultaneously toward the anus and head and open the peritoneal cavity with your scissors, cutting toward each thigh and the anus. With the tines of your scissors together, move the fat toward the anus and the visceral organs toward the head to expose the uterine horns. (vi) Remove the uterine horns from the pregnant dam by gently grabbing each horn between decidual swellings; gently elevate them toward the ceiling, and make three cuts: one between each ovary and its oviduct, and one at the cervix. The uterine organ should now be liberated. Snip away as much fat as possible from the uterine horns and place them into the lid of the 60-mm dish.  crItIcal step The total dissection period from the time of removal of the uterine horns to reflection of the Reichert's membrane begins now, and should take no longer than 30 min (preferably 10-20 min). (vii) Reflection of uterine muscle and liberation of decidua (5 min) . Transfer the uterus to the deep portion of the 60-mm tissue culture dish. Bring the dish with the uterine horns to the dissection microscope. Turn on both epi-and trans-illumination.  crItIcal step Work at the lowest magnification possible (typically ×7.5 total magnification), with both forceps and arms resting on glove boxes or other similar supports. The supports will transfer tension from your arms, thereby relaxing your wrists for dissection. (viii) Locate the puffiest side of the first implantation site, closest to where the uterus was snipped from one of the ovaries, and with your robust forceps tear through the two uterine muscle layers on one face and pick away at these until one decidual half is exposed (supplementary Video 1).  crItIcal step You must coordinate your forceps to work closely together. Do not pull or tear tissue with forceps far apart or you may rupture the cavities in your embryos. Use your robust forceps for tearing the uterine muscle and in later steps for manipulating the decidual swellings. (ix) With one forceps, grip the uterus between the exposed implantation site and the next unexposed one. With the other forceps, squeeze the uterine tissue near the same site but closest to the exposed deciduum, tines together, and shell out the exposed deciduum. Repeat this with each implantation site (supplementary Video 1).  crItIcal step Do not place pressure on the implantation sites as you reflect the muscle, as this will cause deflation of the conceptus inside. (x) With forceps, transfer all decidua to the deep part of a 35-mm dish containing embryo dissection medium and count them as you do this (supplementary Video 2).  crItIcal step Grab each decidual swelling at its widest diameter; the conceptus is in the opposite pole. (xi) Split decidual swellings to expose conceptuses (5 min) . Increase the magnification slightly, and gently stabilize the wider part of each deciduum between the tines of one forceps. With the other forceps, tines together, pierce the decidual dimple, located in the band of maternal blood, at a 60° angle to the bottom of the dish (supplementary Video 3).  crItIcal step Make sure that the tips of the tines of your impaling forceps travel through the entire deciduum and rest on the bottom of the dish. (xii) Slightly separate the decidual halves with the same forceps. With the other forceps, clip the wider part of the deciduum that does not contain the embryo (supplementary Video 3). (xiii) Rotate the deciduum 90°, so that the wider part is at the top of your visual field. With palms facing down, hold your forceps and apply even but gentle pressure to each decidual wall; split the deciduum into two halves with a vertical downward motion. The embryo with its associated trophoblast will stay with one of the halves (supplementary Video 3).  crItIcal step If the decidual halves begins to tear, you must stop, and insert your forceps at the vertex of the split and snip the walls. Resume pulling as described above (supplementary Video 3). (xiv) Release the conceptuses from the decidual halves and reflect the Reichert's membrane (10 min) . With the tines of one forceps separated, impale the exposed decidual half and its embryo, pinning them to the bottom of the dish, and with the tines of the other forceps together scrape the embryo out (supplementary Video 4). (xv) When all the embryos have been scraped out, transfer them via a 9-inch sterile Pasteur pipette, maintaining them close to the pipette opening, to the lid of the 35-mm dish that contains dissection medium. Count as you transfer, making sure that the number of conceptuses transferred is the same as the number of dissected decidua, unless a deciduum was empty because of resorption (Fig. 5) .  crItIcal step The ends of the Pasteur transfer pipettes should be smooth, not jagged; otherwise. embryos may become stuck to the glass or become damaged during transfer. (xvi) Using both pairs of fine forceps, pinch the trophoblast, associated parietal endoderm and its Reichert's membrane (all three tissues are collectively, and informally, called the 'Reichert's membrane') at the embryonic/extraembryonic junction. With one of the forceps, reflect the Reichert's membrane toward the embryo's distal end, rounding that end, and allowing the Reichert's membrane to retract toward the extraembryonic region (supplementary Video 5).  crItIcal step Turn off the epi-illumination. This will allow the Reichert's membrane to be more readily visualized by trans-illumination only. Place your embryos side by side and eliminate any suspected small resorbing embryos (Fig. 5) . If you are not certain, reflect anyway. (xvii) Trim away enough of the reflected membrane so that the embryos can be staged 35 (supplementary Video 6).
(xviii) Staging of embryos (10 min) . Place the reflected embryos into a 35-mm dish containing fresh dissection medium and stage them 35 . If the embryos are at the appropriate stages (2-to 3-somite stage), you can use them immediately for cell injection, or place them in 500 µl of whole-embryo culture medium in an organ culture dish and return the dish to the incubator until the cells are ready for injection.  pause poInt The reflected embryos will be stable in this dish at RT (≤64 °F) for ~90 min. (xix) For any embryos that are not at the correct stage, two things can happen: (i) if they are too young, you can incubate them in organ culture dishes in whole-embryo culture medium until they reach 2-3 somites a few hours later, or (ii) they may be fixed in 4% paraformaldehyde in preparation for other types of experiments-e.g., immunostaining 33 .  crItIcal step Twins and resorbing embryos should be discarded (Fig. 5) ; if ≥30% of embryos are resorbed and/or are resorbing, the entire litter should be discarded.
(xx) Injection of iCPCs into the cardiac crescent of living mouse embryos and ex vivo whole-embryo culture (24 or 48 h).
Singularize cells from
Step 42B(i) using 0.25% trypsin-EDTA, and suspend GFP + iCPCs/cardiac fibroblasts at a density of 1,000-1,200 cells/µl in fibroblast medium and place them on ice until embryo injections.  crItIcal step Well-separated single cells are required for this procedure, and not cell clumps. Verify the absence of cell clusters under the microscope before proceeding, and aspirate only well-separated cells. (xxi) Remove one embryo from the organ culture dish and place it into the center of the lid of a 60-mm tissue culture dish filled with embryo dissection medium. Immediately place the organ culture dish and remaining conceptuses back into the incubator.  crItIcal step Do not leave your conceptuses on the bench in whole-embryo culture medium, as the medium is not buffered for atmosphere and the pH will quickly change. (xxii) Using a glass scorer, cut the injection pipette at its base so that it is half the original size and load it into the aspirator assembly. (xxiii) Just before the injection, resuspend iCPCs or control fibroblasts and place 10 µl of the cells into the base of a 35-mm dish and cover it. Aspirate ~1 µl of cells into the injection pipette. This requires active aspiration rather than capillary action (supplementary Video 7).  crItIcal step In the dissection microscope, verify that the iCPCs are not clumped. Verify that the medium and your cells have reached equilibration in the capillary after you cease to aspirate. If the cells continue to enter, the opening of your injection pipette is too large and you must replace it. (xxiv) While maintaining the aspirator's mouthpiece in your mouth, its capillary in your injection hand and the forceps in your other hand, orientate your embryo so that its cardiac crescent is facing upward. Gently squeeze the embryo and aim your injection pipette at the cardiac crescent (supplementary Video 8).  crItIcal step It is useful to practice the injection on 1-2 embryos to gauge the batch of injection pipettes and your stability. The lid of the 60-mm dish is preferred over the base for performing injections, as the walls of the lid are much lower, and will not interfere with the injection. (xxxvi) Remove the secondary antibody solution and wash the embryos five times with embryo blocking solution for 1 h per wash at RT on a rocker. (xxxvii) Mount the embryos on coverslips using melted agarose and place them in depression slides. Use an epifluorescence, confocal or multiphoton microscope for imaging whole-mount embryos. Injected iCPCs should express markers of cardiac differentiation (Fig. 6e) .  crItIcal step Imaging should be performed within 1 week after mounting, as staining intensity will progressively decrease owing to the absence of antifade agents in agarose. Frequent medium changes Replace iCPC induction medium every 6-7 days until colonies form
Step 36A(vii) and 36B(xviii) iCPC colonies do not expand upon passaging
Colonies were split too soon Allow colony size to reach at least 3-4 mm in diameter or wait for 3-4 weeks after doxycycline induction
Split ratio too high For early passages (1-3), we recommend a 1:3 split ratio. For Passage 4 onward, we recommend a 1:6 split ratio Doxycycline was removed too early Doxycycline induction should be maintained for at least 40 days or 2 passages.
Forgot to add LIF, BIO LIF, BIO must be added at the appropriate concentration to expand iCPC colonies (continued)
